ARCHIVES

FDA Approves Generic Oncology Injectable Currently In Shortage

This article is from The Cancer Letter archive.

Vol. 39 No. 36 | September 27, 2013

Download PDF Visit The Full Archive

Related Articles

NCI Prepares For Intramural Program Review

June 27, 2014

Drug Effectiveness Weakens After Three Years, Study Says

May 27, 2011

HHS System Of Misconduct investigation Not Suited For Clinical Trials, Broder Says

November 11, 1994

NIH On R29 Phase-Out; Grant Review Appeals Process Changed

January 23, 1998

In Brief: Senate Markup Of Cancer Act Renewal Bill Delayed Again; New Money Levels Considered Still Too Low

November 9, 1979

Final Issue of 1981

December 11, 1981